The U.S. Department of Justice said on Thursday that Novartis Hellas, a Greece-based unit of the Swiss drugmaker, entered a deferred prosecution agreement and will pay a $225 million criminal fine. Novartis will also pay $112.8 million to settle related civil charges by the U.S. Securities and Exchange Commission. Novartis AG and a former eye-care … The post Novartis Hellas to pay $225 million to resolve U.S. bribery charges appeared first on Keep Talking Greece.